First Fiduciary Investment Counsel Inc. grew its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,314 shares of the company’s stock after purchasing an additional 131 shares during the period. First Fiduciary Investment Counsel Inc.’s […]